Get access

Unboosted versus boosted atazanavir for reducing morbidity and mortality in people with HIV/AIDS

  • Major change
  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine whether unboosted atazanavir-containing regimens are more effective and safe than boosted atazanavir-containing regimens in reducing morbidity and mortality in people living with HIV/AIDS.

Get access to the full text of this article